Rare lephants
Screener

Fate Therapeutics, Inc.

FATE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Aug 21, 2023 FORM 4 SUBMISSION
144 Aug 18, 2023
10-Q Aug 8, 2023 10-Q
8-K Aug 8, 2023 8-K
4 Aug 7, 2023 FORM 4 SUBMISSION
144 Aug 4, 2023
4 Jul 6, 2023 FORM 4 SUBMISSION
4 Jul 6, 2023 FORM 4 SUBMISSION
144 Jul 5, 2023
144 Jul 5, 2023
4 Jun 15, 2023 FORM 4 SUBMISSION
144 Jun 14, 2023
8-K Jun 9, 2023 8-K
4 Jun 8, 2023 OWNERSHIP DOCUMENT
4 Jun 8, 2023 OWNERSHIP DOCUMENT
8-K Jun 8, 2023 8-K
4 Jun 7, 2023 FORM 4 SUBMISSION
4 Jun 7, 2023 FORM 4 SUBMISSION
4 Jun 7, 2023 FORM 4 SUBMISSION
4 Jun 7, 2023 FORM 4 SUBMISSION
4 Jun 7, 2023 FORM 4 SUBMISSION
4 Jun 7, 2023 FORM 4 SUBMISSION
4 Jun 7, 2023 FORM 4 SUBMISSION
4 Jun 7, 2023 FORM 4 SUBMISSION
8-K Jun 7, 2023 8-K
← Newer Page 9 of 35 · 855 filings Older →